If I’m not mistaken, there hasn’t been one trial With Brilacidin where it didn’t show effectiveness against the targeted malady. I have high confidence in the upcoming testing the week of May 4. The real question is, will the right people know about successful results? That seems like the biggest hurdle but Leo has B in the right place at the right time for recognition upon success. A joint trial with Gilead’s Remdesivir and IPIX’s Brilacidin would be huge!